HPV Message Testing and Social Media Campaign
Primary Purpose
Vaccine, Human Papilloma Virus
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Social Media Message about HPV and HPV vaccine
Social media message about risk of electronic cigarettes.
Sponsored by
About this trial
This is an interventional health services research trial for Vaccine focused on measuring Adolescence, Attitudes, Parents, Vaccination
Eligibility Criteria
Inclusion Criteria:
- parents of children 9-14 years old
Exclusion Criteria:
- non-parents
Sites / Locations
- Dartmouth-Hitchcock Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
HPV Messaging
Control Message
Arm Description
Subjects are randomized to receive one of five messages on one of the four themes about HPV vaccination.
Subjects are randomized to receive one of five messages about electronic cigarettes.
Outcomes
Primary Outcome Measures
Change in Attitudes About HPV Vaccine
Change in Attitudes about HPV vaccine: Pre to post test comparison of summated 9 items measured on a 7-point scale of HPV vaccine attitudes. Scores range from a minimum of 9 to a maximum of 63. Higher scores indicated more positive attitudes toward HPV vaccination. Change was calculated from two time points, the later time point(<1 hour post messaging intervention) minus value at baseline.
Secondary Outcome Measures
Behavioral Intention to Vaccinate Their Child With HPV Vaccine
A sub-group of parents of 9-14 year old children who had not been vaccinated were asked on pre- and post-test: How likely is it that she/he will receive the HPV vaccine in the next 12 months? Responses range form 1 (very likely) to 5 (not very likely).
HPV vaccination behavioral intent change scores were calculated by subtracting pre- and post- test values. It is a negative-value scale, in which smaller values indicate more positive attitude change after exposure to the viewed message.
Full Information
NCT ID
NCT03747302
First Posted
November 16, 2018
Last Updated
August 19, 2022
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
National Cancer Institute (NCI), Norris Cotton Cancer Center
1. Study Identification
Unique Protocol Identification Number
NCT03747302
Brief Title
HPV Message Testing and Social Media Campaign
Official Title
HPV Message Testing and Social Media Campaign
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
December 12, 2018 (Actual)
Primary Completion Date
September 9, 2019 (Actual)
Study Completion Date
September 9, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
National Cancer Institute (NCI), Norris Cotton Cancer Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vaccine, Human Papilloma Virus
Keywords
Adolescence, Attitudes, Parents, Vaccination
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
Participants are not aware of which arm of social messaging they are receiving and whether they are receiving the control message or not
Allocation
Randomized
Enrollment
1043 (Actual)
8. Arms, Groups, and Interventions
Arm Title
HPV Messaging
Arm Type
Experimental
Arm Description
Subjects are randomized to receive one of five messages on one of the four themes about HPV vaccination.
Arm Title
Control Message
Arm Type
Other
Arm Description
Subjects are randomized to receive one of five messages about electronic cigarettes.
Intervention Type
Other
Intervention Name(s)
Social Media Message about HPV and HPV vaccine
Intervention Description
Messages educate parents with facts about HPV vaccination.
Intervention Type
Other
Intervention Name(s)
Social media message about risk of electronic cigarettes.
Intervention Description
Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.
Primary Outcome Measure Information:
Title
Change in Attitudes About HPV Vaccine
Description
Change in Attitudes about HPV vaccine: Pre to post test comparison of summated 9 items measured on a 7-point scale of HPV vaccine attitudes. Scores range from a minimum of 9 to a maximum of 63. Higher scores indicated more positive attitudes toward HPV vaccination. Change was calculated from two time points, the later time point(<1 hour post messaging intervention) minus value at baseline.
Time Frame
Post test completed < 1 hour post messaging intervention
Secondary Outcome Measure Information:
Title
Behavioral Intention to Vaccinate Their Child With HPV Vaccine
Description
A sub-group of parents of 9-14 year old children who had not been vaccinated were asked on pre- and post-test: How likely is it that she/he will receive the HPV vaccine in the next 12 months? Responses range form 1 (very likely) to 5 (not very likely).
HPV vaccination behavioral intent change scores were calculated by subtracting pre- and post- test values. It is a negative-value scale, in which smaller values indicate more positive attitude change after exposure to the viewed message.
Time Frame
Ore test immediately before viewing message and post- test immediately after viewing message. Approximately one hour.
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
parents of children 9-14 years old
Exclusion Criteria:
non-parents
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ardis L Olson, MD
Organizational Affiliation
Trustees of Dartmouth College
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dartmouth-Hitchcock Medical Center
City
Lebanon
State/Province
New Hampshire
ZIP/Postal Code
03756
Country
United States
12. IPD Sharing Statement
Links:
URL
https://www.dhhs.nh.gov/sites/g/files/ehbemt476/files/documents/2021-11/hpv-nh-1999-2013.pdf
Description
HPV cancer diagnosis rates
URL
http://www.healthvermont.gov/sites/default/files/documents/pdf/stat_cancer_HPV_Assoc_Ca_Data_Brief.pdf
Description
HPV cancer diagnosis rates
URL
https://www.cdc.gov/mmwr/volumes/66/wr/mm6633a2.htm
Description
HPV vaccination rates
Learn more about this trial
HPV Message Testing and Social Media Campaign
We'll reach out to this number within 24 hrs